Biomarkers for intracellular pathogens: establishing tools as vaccine and therapeutic endpoints for visceral leishmaniasis.
about
Systematic review of biomarkers to monitor therapeutic response in leishmaniasisBiomarkers of safety and immune protection for genetically modified live attenuated leishmania vaccines against visceral leishmaniasis - discovery and implications.IgG1 as a potential biomarker of post-chemotherapeutic relapse in visceral leishmaniasis, and adaptation to a rapid diagnostic testFrom mouse to man: safety, immunogenicity and efficacy of a candidate leishmaniasis vaccine LEISH-F3+GLA-SE.Mobile suitcase laboratory for rapid detection of Leishmania donovani using recombinase polymerase amplification assayTransmission Dynamics of Visceral Leishmaniasis in the Indian Subcontinent - A Systematic Literature ReviewStudy on the safety and efficacy of miltefosine for the treatment of children and adolescents with post-kala-azar dermal leishmaniasis in Bangladesh, and an association of serum vitamin E and exposure to arsenic with post-kala-azar dermal leishmaniaLeishmania vaccine development: exploiting the host-vector-parasite interface.Post-Kala-Azar Dermal Leishmaniasis Without Previous History of Visceral Leishmaniasis.Accurate Serodetection of Asymptomatic Leishmania donovani Infection by Use of Defined AntigensReal-time PCR in detection and quantitation of Leishmania donovani for the diagnosis of Visceral Leishmaniasis patients and the monitoring of their response to treatment.Cytokines and chemokines measured in dried SLA-stimulated whole blood spots for asymptomatic Leishmania infantum and Leishmania donovani infection.Real-time PCR applications for diagnosis of leishmaniasis.Evaluation of Real-time PCR for Diagnosis of Post-Kala-azar Dermal Leishmaniasis in Endemic Foci of Bangladesh
P2860
Q26866450-18089FEC-7988-48DC-8322-080E771F2D87Q33659753-A344D422-F21A-462A-95AA-C4173969707CQ34395015-2B3CDF67-1177-49A7-995D-81C68B0162BCQ35809113-894978F0-0921-4707-89AD-EF4D98EF69C6Q36017628-9EA7BCDF-1482-4501-B647-C9E8DA773D1FQ36094815-7899C4CD-0667-463C-8416-F1C495C7CCAEQ36920274-09C6C071-B98E-4B4C-A8FD-B2941DAF14F6Q38643410-AA7246E0-BF86-46E2-84B2-096F87657382Q39052807-664E97EC-EF43-4D3B-8A2F-D9D08FA60943Q39577607-4C54B5C3-353C-4978-B1B3-D80DFF1DF780Q41993422-2A3F15B0-F571-4302-B259-D5B98CACDC98Q47156228-07164B08-4CD0-4C98-B807-1843E2D7FFD7Q55311477-09F00447-9A45-4357-9A9C-A86BA41E2C17Q57493430-3DDFD9BB-01ED-4235-A89F-53ED2E0DE3B8
P2860
Biomarkers for intracellular pathogens: establishing tools as vaccine and therapeutic endpoints for visceral leishmaniasis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Biomarkers for intracellular p ...... ts for visceral leishmaniasis.
@en
Biomarkers for intracellular p ...... ts for visceral leishmaniasis.
@nl
type
label
Biomarkers for intracellular p ...... ts for visceral leishmaniasis.
@en
Biomarkers for intracellular p ...... ts for visceral leishmaniasis.
@nl
prefLabel
Biomarkers for intracellular p ...... ts for visceral leishmaniasis.
@en
Biomarkers for intracellular p ...... ts for visceral leishmaniasis.
@nl
P2093
P2860
P356
P1476
Biomarkers for intracellular p ...... ts for visceral leishmaniasis.
@en
P2093
A C Vallur
C Reinhart
K R H Bhaskar
Y Tutterrow
P2860
P304
P356
10.1111/1469-0691.12421
P50
P577
2013-11-18T00:00:00Z